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Abstract: The Holmium:yttrium-aluminum-garnet (Ho:YAG) laser has been the gold-standard for laser 
lithotripsy over the last 20 years. However, recent reports about a new prototype thulium fiber laser (TFL) 
lithotripter have revealed impressive levels of performance. We therefore decided to systematically review 
the reality and expectations for this new TFL technology. This review was registered in the PROSPERO 
registry (CRD42019128695). A PubMed search was performed for papers including specific terms relevant 
to this systematic review published between the years 2015 and 2019, including already accepted but not 
yet published papers. Additionally, the medical sections of ScienceDirect, Wiley, SpringerLink, Mary Ann 
Liebert publishers, and Google Scholar were also searched for peer-reviewed abstract presentations. All 
relevant studies and data identified in the bibliographic search were selected, categorized, and summarized. 
The authors adhered to PRISMA guidelines for this review. The TFL emits laser radiation at a wavelength 
of 1,940 nm, and has an optical penetration depth in water about four-times shorter than the Ho:YAG laser. 
This results in four-times lower stone ablation thresholds, as well as lower tissue ablation thresholds. As 
the TFL uses electronically-modulated laser diodes, it offers the most comprehensive and flexible range 
of laser parameters among laser lithotripters, with pulse frequencies up to 2,200 Hz, very low to very high 
pulse energies (0.005–6 J), short to very long-pulse durations (200 µs up to 12 ms), and a total power level 
up to 55 W. The stone ablation efficiency is up to four-times that of the Ho:YAG laser for similar laser 
parameters, with associated implications for speed and operating time. When using dusting settings, the TFL 
outperforms the Ho:YAG laser in dust quantity and quality, producing much finer particles. Retropulsion is 
also significantly reduced and sometimes even absent with the TFL. The TFL can use small laser fibers (as 
small as 50 µm core), with resulting advantages in irrigation, scope deflection, retropulsion reduction, and (in)
direct effects on accessibility, visibility, efficiency, and surgical time, as well as offering future miniaturization 
possibilities. Similar to the Ho:YAG laser, the TFL can also be used for soft tissue applications such as 
prostate enucleation (ThuFLEP). The TFL machine itself is seven times smaller and eight times lighter than 
a high-power Ho:YAG laser system, and consumes nine times less energy. Maintenance is expected to be very 
low due to the durability of its components. The safety profile is also better in many aspects, i.e., for patients, 
instruments, and surgeons. The advantages of the TFL over the Ho:YAG laser are simply too extensive to be 
ignored. The TFL appears to be a real alternative to the Ho:YAG laser and become a true game-changer in 
laser lithotripsy. Due to its novelty, further studies are needed to broaden our understanding of the TFL, and 
comprehend the full implications and benefits of this new technology, as well its limitations.
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Introduction
More than 30 years have passed since laser lithotripsy became 
a reality (1-3). It quickly found widespread acceptance among 
urologists in the late 1980s (4-6), and in less than 10 years, 
the Holmium:yttrium-aluminum-garnet laser (Ho:YAG) 
rapidly became the gold-standard for endoscopic laser 
lithotripsy (7-11), remaining the uncontested reference in 
this medical field over the last 20 years. 
However, there has been increasing interest in a new 
thulium fiber laser (TFL) lithotripter (12), which has 
been cleared for clinical use in the Russian Federation 
and launched in that market in 2018. According to some 
authors, it seems to be one of the most promising new 
laser technologies for lithotripsy, being several times more 
efficient than the current gold-standard Ho:YAG laser, as 
well as presenting other advantages (13-15). In view of these 
reports, we decided to review the latest advances in this 
technology and evaluate the reality and expectations of the 
new TFL lithotripter, thereby helping the reader to create 
an objective and evidence-based opinion.
Methods
This review was registered in PROSPERO (16-18), the 
international database of prospectively registered systematic 
reviews, with the PROSPERO registration number 
CRD42019128695. A PubMed search was performed 
(February 2019) for papers including the terms “holmium” 
or “thulium” in association with any of the following terms 
“lithotripsy”, “lithiasis”, “stone(s)”, “calculus”, “calculi”, 
“lithotripter(s)”, “lithotrite(s)”, “fiber(s)”, “fibre(s)”, “(endo)
urology”, (endo)urologic(al)”, or “intrarenal”. The search 
covered articles published between the years 2015 and 
2018, as well as articles already accepted in 2019 but not 
yet published. The search was deliberately kept as wide-
ranging as possible to ensure that any paper about thulium 
fiber lasers would be found. Furthermore, because of the 
scarcity of results (see Results section), and in line with 
another systematic review that we published in the past (19), 
the medical sections of ScienceDirect, Wiley, SpringerLink, 
and Mary Ann Liebert publishers as well as Google Scholar 
were also searched for peer-reviewed abstract presentations 
published within the previously stated time frame that 
were not indexed on PubMed. Moreover, key papers and 
other important studies on the subject were also included 
and cross-referenced if they were considered noteworthy, 
despite being published before 2015. The authors adhered 
to PRISMA guidelines for this review (20). All relevant data 
was identified and selected, and is summarized below. 
Results
The PubMed search returned 1,834 articles whose abstracts 
were read. The majority of these articles (1,181 articles) 
related to basic technical laser research, not directly to 
medicine. They included research into new laser media, 
fiber production, soliton and quantum research, proof of 
concept for new laser systems, communications, imaging, 
nanotubes, and random bit generators created with lasers; 
most of these articles were published in journals specializing 
in the wide-ranging field of optics, and were hence indexed 
in PubMed. A total of 155 other articles were related to 
the use of lasers in non-urological medical specialties such 
as ophthalmology, gastroenterology, ENT, vascular and 
general surgery, interventional radiology, pneumology, 
dermatology, and cosmetics.
The remaining 498 articles concerned urology-related 
fields, with 233 dealing with the use of lasers in a non-
lithotripsy-related setting such as holmium laser enucleation 
of the prostate (HoLEP) and greenlight-laser or other laser 
ablative techniques. Finally, the last 265 articles were related 
to urological laser lithotripsy. As expected, the vast majority 
of these papers were exclusively about holmium lithotripsy. 
Only 20 papers mentioned the TFL or topics related to it, 
yet some of these papers were not directly about the TFL, 
although some generic reviews mentioned it among other 
themes. Fortunately, the searches of the medical sections 
of ScienceDirect, Wiley, SpringerLink, Mary Ann Liebert, 
and Google Scholar which returned many of the papers 
already picked up in the PubMed search, allowed us to 
scrutinize the abstract presentations of the major urology 
congresses over recent years (21-36), and older reference 
papers, resulting in 35 additional sources of information 
about the TFL. The source of information selection process 
is summarized in Figure 1.
With the present paper’s objective in mind, we wrote 
an introductory summary about the Ho:YAG laser called 
“Ho:YAG laser—the current gold-standard” to highlight its 
importance as the gold-standard over the last 20 years and 
to better contextualize the results of the present systematic 
review. The relevant data retrieved from the bibliographic 
search have been categorized and summarized into a section 
called “TFL—the theory”, which discusses the concept 
behind the TFL, while a longer section entitled “TFL—the 
practice” discusses the practical issues relating to this new 
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technology. 
Ho:YAG laser—the current gold-standard
Ho:YAG laser lithotripters can efficiently fragment 
any stone composition, and can also be used for other 
applications including soft-tissue ablation, HoLEP, tumor 
resections, and management of stricture disease (11,37-41). 
As the majority of Ho:YAG energy is absorbed by water 
within 0.4 mm of the laser fiber tip, it is also very safe to 
use in an aqueous environment, i.e., in any endourological 
setting (41-43).
In the early days, the Ho:YAG laser lithotripter only 
had two parameters that the urologist could manipulate: 
the pulse energy in Joules (J) and the pulse repetition rate, 
commonly referred to as frequency, in Hertz (Hz). With 
very few parameter combinations possible, the user was 
limited to low pulse energies (up to 2 J), low frequencies 
(up to 15 Hz), and low total power levels (15 to 20 Watts 
maximum) (19,44,45).
Presently, several high-power Ho:YAG lasers are 
available, and these are capable of attaining much higher 
pulse energies (up to 6 J), very high pulse frequencies (up 
to 100 Hz), and higher total power levels (up to 140 W), 
thereby overcoming past limitations (46-50). These higher 
frequencies enabled a new laser lithotripsy philosophy, 
namely, the ability to ‘dust’ urinary stones quickly and 
efficiently, avoiding the need for capricious and time-
consuming maneuvers associated with the removal of 
residual stone fragments (19,51-54). 
The same progress that resulted in more powerful 
Ho:YAG laser lithotripters also led to the development of a 
third parameter for the surgeon to manipulate, the ability to 
control the pulse duration (i.e., pulse length) and pulse shape, 
with consequent reduction of stone retropulsion and laser 
fiber-tip degradation (41,55-60). Besides the standard short-
pulse mode, one can currently choose medium-, or long-
pulse modes, depending on the Ho:YAG model (56,61-64).
Another special feature for further reduction of stone 
retropulsion and increase in ablation rates has recently 
become available, and was termed “Moses technology” by 
the Ho:YAG laser manufacturer Lumenis™ (46). It consists 
in delivering a short, low energy pulse to create a vapor 
bubble before delivering the actual ablative energy pulse (65). 
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Other Ho:YAG laser manufacturers also utilize similar 
techniques but use different terms and tradenames such as 
“Stabilization Mode” (48), “Vapor Tunnel” (47), or “Virtual 
Basket Technology” (66). Developments in the technology 
have not ended, with other customized approaches to laser 
pulse delivery such as burst laser lithotripsy (67) as well 
as even more powerful and feature-rich Ho:YAG laser 
lithotripters on the horizon (49,50).
This gradual and continuous Ho:YAG laser evolution, 
with the ability to ablate any type of urinary stone, and the 
capacity to cut, coagulate, ablate, enucleate, and vaporize 
tissues, as well as the technology’s excellent safety profile, 
make the Ho:YAG laser the safest, most versatile, and most 
successful type of laser currently used in urology.
TFL—the theory
The following section provides a review of the theoretical 
aspects of the TFL, and then compares it to the Ho:YAG 
laser.
Wavelengths, water absorption coefficient, and ablation 
thresholds
The pulsed infrared light emitted by current Ho:YAG lasers 
used in lithotripsy has, according to the manufacturers, a 
wavelength of approximately 2,100 nm (2,090 to 2,120 nm) 
(44,46,47,50,68-72). By contrast, the light emitted by TFLs 
has a wavelength tunable between 1,810 and 2,100 nm by 
fiber laser design. However, most preclinical research was 
done with TFLs using 1,908 and 1,940 nm wavelengths, 
with most of the abstracts and papers published in the last 
4 years referring to a pulsed (or super-pulsed) TFL using 
a 1,940 nm wavelength (73-84). The TFL is not to be 
confused with another thulium laser, the continuous wave 
Thulium:YAG laser (about 2,000 nm wavelength), which is 
used exclusively for prostate ablation and vaporization, and 
which is unsuitable for lithotripsy (85).
Both the Ho:YAG laser and TFL energies are highly 
absorbed by water. However, while the holmium laser 
radiation at the 2,090 nm wavelength has an absorption 
coefficient of α=31.8 cm−1 at 20 ℃ (86), thulium laser 
radiation at the 1,940 nm wavelength is nearer to the 
absorption peak of water and has an α=129.2 cm−1 (87). 
These correspond to water optical penetration depths of 
0.314 mm for the Ho:YAG lasers and 0.077 mm for the 
TFL. Thus, the TFL’s optical penetration depth is four-
times less than that of the Ho:YAG laser. However, the 
optical penetration depth is a non-linear measure, being 
based on exponentiation of the mathematical constant e 
(e=2.7182), the Euler’s number forming the base of the 
natural logarithm. This means that the energy of a laser 
beam passing through water will be reduced by a factor of 
e (2.78182) for each successive optical penetration depth 
it passes through (i.e., it will be reduced by ~63%). For 
example, a Ho:YAG laser energy pulse in water will have 
been reduced to 37% of its initial energy after traveling 
a distance corresponding to its optical penetration depth, 
while a TFL energy pulse will have been reduced to 1.7% 
over the same distance (Figure 2). At 1 mm, the Ho:YAG 
pulse will still have 4% of its initial intensity, while the 
TFL pulse will have almost vanished, with an undetectable 
0.00024% of its initial intensity. Thus, although the optical 
penetration depth of the TFL is only a quarter of that of 
the Ho:YAG laser, the logarithmical nature of radiation 
Figure 2 Relationship between absorption coefficient α, optical penetration depth (OPD), and energy inside water at 20 ℃. The figure 
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absorption means that for a 1 mm distance, the TFL has 
been absorbed approximately 16,000 times more than the 
Ho:YAG laser. In cases where laser energy produces vapor 
bubbles, these distances are extended for both the TFL 
and the Ho:YAG laser, changing during every laser pulse 
due to vapor bubble channel expansion and collapse (see 
Retropulsion and “Moses” capabilities section below), but 
the previously described relationship is always maintained.
The higher water absorption coefficient at the TFL 
wavelength directly translates into lower water-, (water-
containing) tissue ablation-, and vapor-channel-initiation 
thresholds (65,88) than required for the Ho:YAG laser. 
Incidentally, the same applies for lithotripsy. The ablation 
thresholds for different urinary stone compositions such 
as harder calcium oxalate monohydrate or softer uric 
acid stones are four-times lower for the TFL than for 
the Ho:YAG laser (15,65,74,89). This has the following 
implications: first, the TFL is able to ablate a significantly 
higher stone volume than a Ho:YAG laser at the same 
lithotripter settings; second, the TFL can use much lower 
energy settings (approximately four-times less) than any 
Ho:YAG laser while achieving the same stone ablation 
results; and third, as an extension of the previous point, 
the TFL will be less prone to retropulsion because it can 
achieve the same ablation rates as the Ho:YAG laser, but at 
lower energy settings.
Thulium fiber laser assembly—what’s inside?
One of the authors of the present paper performed a recent 
review on the internal construction of the new TFL and 
compared it with the Ho:YAG laser (90). To summarize 
briefly, the construction of a Ho:YAG laser requires a flash 
lamp powered by a high-voltage power supply that “injects” 
light (i.e., photons) into a several millimeters diameter 
and several centimeters long laser crystal rod containing 
holmium ions (the gain medium). This laser crystal rod 
then emits photons at the desired holmium wavelength 
of 2,100 nm, i.e., the Ho:YAG laser radiation. This laser 
radiation then travels back and forth between two reflective 
mirrors located at each end of the crystal rod (mirrors 
which must be aligned with extreme precision) to be formed 
into a straight collimated laser beam. To make this process 
effective, all of these components are contained inside a 
reflective cavity, and the flash lamp pulse continuously 
“pumps” light into the laser rod. The whole assembly of 
components is called a laser resonator or cavity (91,92). 
One of the two reflective mirrors allow some of the laser 
radiation to escape to form the actual laser output beam. 
This several mm-wide laser beam must then be focused 
through a system of lenses to fit inside the small core of a 
surgical laser fiber to be delivered to its final target (stones 
or tissues).
Differing from the Ho:YAG laser, the TFL uses several 
simple laser diodes as the energy light source, instead of a 
flash lamp (89,90,93,94). The gain medium producing the 
1,940 nm TFL laser beam is a simple and very long thulium-
ion containing active fiber with a very thin fiber core 
(10–20 µm core diameter) (90,95). Because the laser beam 
originates inside this small fiber core, the TFL laser beam 
can be directly coupled to and delivered through another 
attachable laser fiber to carry the beam to its target (73). 
Table 1 summarizes most of the technology-related 
specifications.
TFL—the practice
This section deals with the practical aspects of the TFL 
technology and its capabilities, performance, and potential 
applications, as well as documenting the technical and safety 
related issues, i.e., the important and relevant information 
for surgeons.
Laser setting specifications
Since the TFL uses electronically-modulated laser diodes 
(89,92), a comprehensive range of laser lithotripter 
parameters are available for adjustment, and the frequency, 
pulse energy, and pulse length/duration ranges are larger 
and more flexible than those previously available for other 
types of laser lithotripters (Figure 3).
Pulse frequency
The current TFL medical systems (IRE-Polus, Fryazino, 
Russia, which is a subsidiary of IPG Photonics Co, Oxford, 
MA) (12,97,98) are capable of reaching a frequency of up 
to 2,200 Hz (12,65,76,79,90). This very high frequency 
contrasts with that of the Ho:YAG lasers, which are 
physically limited to 30 Hz or lower because of thermal 
effects and thermo-lensing caused by heat energy from the 
flash lamp on the laser crystal rod (65,93). Ho:YAG laser 
manufacturers have overcome this limitation by combining 
multiple laser resonators (laser cavities) to obtain more 
powerful lithotripters capable of higher frequencies (80 to 
100 Hz) despite the much added expense (15,46,47,49,90); 
however, the frequencies available are still nowhere near to 
those achievable with the TFL. 
Pulse energy
The TFL is able to reach maximum pulse energies of 
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Table 1 Technology and machine related specifications





Energy (light) source Flash lamp Laser diodes (electronically controlled)
Gain medium Several millimeter-thick laser 
crystal rod (containing holmium 
ions)




Wavelength 2,100 µm (2,090 to 2,120 µm) 1,940 µm (1,908 µm for older models)
Water absorption coefficient 31.8 cm−1 (at 2,090 nm) 129.2 cm−1
Optical penetration depth in 
water
0.314 mm 0.077 mm
Pulse profile Irregular energy pulses, with 
several spikes




Laser coupling into patient 
laser fiber
System of calibrated focusing 
lenses
Almost direct fiber-fiber coupling
Patient laser fiber core 
diameter
200 µm or higher 50 µm or higher  





Pulse energy 0.2–6.0 J 0.025–6.0 J (0.005 J for some prototypes)
Pulse frequency 5–80 (up to 100 Hz in newer 
models)
5 to 2,200 Hz
Pulse duration 50–1,300 µs 200–12,000 µs
Maximum average laser 
power




Size 47 cm × 116 cm × 105 cm 55 cm × 46 cm × 29 cm
Weight 245–300 kg (depending on model) 36 kg
Power supply Dedicated high amperage power 
outlet
Standard/household power outlet
Energy efficiency 1% 12%
Energy consumption 9,000 W 1,000 W
Cooling system Water cooling system Air cooling system
6 J, similar to the maximum pulse energies of the most 
powerful Ho:YAG lasers of today (46,50,68). However, the 
TFL technology also allows the surgeon to use minimal 
pulse energies such as 0.05 or 0.025 J (79,80,82,83,90), and 
sometimes as low as 0.005 J (89), with these being much 
lower than the usual 0.2 J minimum pulse energy achievable 
with current Ho:YAG lasers. Such low energies could be 
of paramount importance, especially when performing a 
dusting procedure, as they could help obtain the smallest 
dust particles possible and keep retropulsion to a minimum.
Pulse duration/pulse length
With the TFL, the operator can choose between short-
pulse durations (e.g., 200 µs) or longer ones (e.g., 1 ms), as 
with the current Ho:YAG lasers (46,47,49,50,89), and it is 
also possible to surpass these values by a factor of 10 and 
achieve pulse durations of up to 12 ms (65,90). However, 
unlike the Ho:YAG lasers, the TFL is not able to emit high 
pulse energies with short-pulse durations (89), which could 
be considered a limitation, although current trends with 
Ho:YAG lasers, including technological developments and 
surgeons’ preferences, are moving towards the use of longer 
pulse durations.
Total power
The current pulsed TFL systems have a maximum total power 
of 50–55 W (12,80,81,89). This contrasts with the higher 
power levels available (100, 120, or even 140 W) for the most 
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recent and powerful Ho:YAG lasers (46,47,49,50). However, 
power levels higher than 30 W are rarely used for lithotripsy 
because of the significant risk of collateral tissue damage from 
the locally high temperatures that can occur with high-power 
lithotripsy (see Safety profile section) (99-101).
Despite TFL technology being relatively new, attempts 
have already been made, using several patient cohorts, to 
determine the optimal settings for lithotripsy using the 
TFL. Suggested settings include 0.1–0.2 J/15–30 W for the 
dusting of kidney stones, 0.2–0.5 J/10–15 W for the dusting 
and fragmentation of ureteric stones, 2–5 J/30–50 W 
for the fragmentation of large bladder stones (84), 1–1.5 J 
and 15–30 Hz for percutaneous nephrolithotomy (PCNL) 
fragmentation, and 0.1–0.3 J and 50–100 Hz for PCNL 
dusting (78). However, these are very preliminary 
recommendations, and the ideal TFL lithotripsy settings 
are far from established, and must be determined in future 
clinical experience-based studies.
Ablation efficiency, speed, and operating room-time
Initial laboratory studies performed with early TFLs showed 
disappointing results because the continuous wave TFLs 
available at that time used significantly lower peak power levels 
(~110 W), and were thus inappropriate for lithotripsy (93). 
In comparison, the popular Ho:YAG lasers were shown to 
be effective lithotripsy tools from the very beginning, being 







From 50 μs up to 1,300 μs
From 200 μs up to…………………………………… 12,000 μs =12 ms
From 0.2, 0.5, 1.0, ………………………up to 6.0 Joules
From 0.025, 0.05, 0.10, 0.2, 0.5, 1.0, ………………up to 6.0 Joules
From 5 to 80 Hz
From 5 to 80 Hz, and up to………………………………2,200 Hz
The Ho:YAG’s pulse profile is irregular, with 
several energy spikes and rapid decline, 
while the TFL’s is almost a square wave, 





Laser settings specifications comparison
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able to reach very high peak powers (102-104).
However, TFL technology has evolved dramatically in 
the last few years, and higher peak powers (~500 W) are 
now attainable, with pulsed and super-pulsed operation 
modes (82). The equipment has been shown to be safe and 
highly efficient, offering improved treatment effectiveness 
for stones of any compositions, sizes, and locations for both 
dusting and fragmentation modes, and using retrograde 
intrarenal surgery, PCNL, micro-PCNL, cystolithotripsy, 
or other endoscopic techniques (73,75-84,97,104-109). 
Currently, multiple authors agree that the TFL is more 
efficient than the Ho:YAG laser, with the most recent studies 
demonstrating the recent 50 W TFL prototypes to be up 
to four-times more ablative for dusting and up to two-times 
more ablative for fragmentation of urinary stones than the 
current 120 W top-of-the-line Ho:YAG lasers (Figure 4) 
(65,79,81,108,109). Other studies have shown that the TFL 
technology has an even higher ablative capacity for both soft 
uric acid and hard oxalate monohydrate urinary stones, being 
5–10 times more efficient than the Ho:YAG laser (13,119).
There are several reasons for the TFLs high efficiency. 
First, although laser lithotripsy is known to predominantly 
be a photothermal ablative mechanism (120), the high water 
absorption of the TFL’s 1,940 nm wavelength laser radiation 
(see The theory section) brings another mechanism into 
play: the water trapped in inter-microcrystal space, pores, 
cracks, and fissures inside the calculi and near the stone’s 
surface vaporizes suddenly in an explosive fashion, creating 
very high pressures in a localized region. These high 
pressures produce mechanical stress waves within the stone, 















Up to 4 time more ablation 
volume with the TFL.
Higher dust quantity and better dust quality 
(smaller dust particles) with the TFL
Significantly less retropulsion with the TFL, 
sometimes even absent or not noticeable.
A smaller fiber size presents several advantages such as:
• Better scope deflection and accessibility 
• More irrigation and better visibility
• Less retropulsion and higher ablation efficiency
• Miniaturization possibilities which directly and indirectly 
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which further ablate the stone, and also remove weakened 
material from the irradiation site (15,65,89,121). With 
Ho:YAG lasers, this water-explosive mechanism has not 
been demonstrated to play a direct role in ablation (120), 
but it might contribute to the TFL’s four-times lower stone 
ablation threshold. Second, the individual temporal pulse 
profiles (pulse shapes in time) of the TFL are symmetrical, 
and show almost perfect square waves with uniform energy 
distribution over time and maintain constant peak power; in 
contrast, the Ho:YAG laser’s pulse profile is asymmetrical, 
with several initial energy spikes during the same pulse, 
followed by a rapid decline (Figure 3), with a steady peak 
power level being currently unattainable (89,96). Third, 
the TFL produces much lower retropulsion without the 
constant need to readjust the laser fiber toward the stone (see 
Retropulsion and “Moses” capabilities section).
A working method or technology may be very effective 
for performing a certain task, but still take a considerable 
amount of time to accomplish the task. However, in the case 
of the TFL, effectiveness and speed go hand in hand, and 
this high efficiency translates into much swifter procedures 
and shorter operating room (OR) times than with the current 
gold-standard Ho:YAG technology (65,109-111,119,122). 
This presents clear benefits for the individual patient, as well 
as decreasing the fatigue of the operating surgeon (80). 
Dust quantity and quality
The ability to dust urinary stones without the need to 
remove residual fragments has been recognized by the 
endourological community as a highly desirable feature of 
a lithotripter (89). In this regard, high-power multi-cavity 
(resonators) Ho:YAG lasers allowing higher frequencies 
have opened a new frontier in dusting capabilities (123,124), 
although the resulting “dust” is more like smaller fragments 
than true dust.
The TFL produces three to four-times more dust than a 
high-power high-frequency Ho:YAG laser at similar power 
levels, even if the “Moses mode” is turned on (79,109-111). 
Besides the TFL’s more ablative and efficient dusting 
settings in terms of primary stone reduction, the resulting 
dust particle quantity is higher and the particle sizes 
smaller than with Ho:YAG lasers: the TFL produces more 
small dust particles under 0.5 mm than the Ho:YAG laser, 
regardless of the stone composition (96). In addition, the 
TFL can produce ultra-small stone particles of less than 
0.1 mm (65), which are much nearer to real dust in size (89) 
(Figure 4). Both the larger quantity and better quality of 
the dust created with the TFL are related to the TFL’s 
higher water absorption and consequent micro-explosive 
water vapor-expansion mechanisms, as well as the clearly 
defined and precise emission of laser energy (89,96,125). 
With its wide-ranging and flexible parameters, the TFL is 
also capable of high-frequency dusting, pop-corning, pop-
dusting, corn-dusting, and micro-dusting.
Retropulsion and “Moses” capabilities
Laser lithotripsy is known to produce a retropulsion effect 
that often forces the urologist to chase after stones up the 
ureter or inside the kidney; it prolongs procedural times 
and may sometimes make urinary calculi inaccessible 
(41,112,126). 
The TFL has been shown to produce much less 
retropulsion than the Ho:YAG laser, sometimes even 
no retropulsion at all when very low pulse energies and 
frequencies under 150 Hz are used (74,83,113). As the 
TFL produces a uniform pulse energy profile, “Moses” 
capabilities occur naturally with the TFL, with it producing 
a stream of multiple bubbles during a single laser pulse (127), 
and each bubble growing and collapsing without 
interference (98). This corresponds to the true “Moses 
effect” originally described by Isner in 1986 (128-130), who 
also coined the expression “Moses effect” (128). Because of 
the lower peak power, the TFL bubble dimensions are four-
times smaller and the generated local pressures ten times 
lower than those of the Ho:YAG laser (127). Even at very 
high pulse energies (3 J), stone retropulsion is three times 
lower with the TFL (81). 
The TFL has been reported to offer a better endoscopic 
view during lithotripsy (80). The reduced retropulsion and 
consequent reduced medium turbulence could possibly be 
responsible for this, as less fragments and dust particles 
are swirled up, thereby reducing the “snow storm” effect 
that is characteristic of Ho:YAG lithotripsy. By producing 
less retropulsion, the TFL is also more readily operated by 
less experienced users, reducing the learning curve and the 
need to constantly adapt to a persistently changing stone 
position. More impressively, with fine tuning of parameters 
and laser fiber positioning, it has been demonstrated that 
the TFL can be used to rapidly and reproducibly pull 
stone samples with a “suction effect”, thereby offering an 
additional tool for manipulating urinary stones during laser 
lithotripsy (131).
50 µm laser fibers, fiber degradation, and 
miniaturization opportunities
The Ho:YAG laser technology has a physical limitation 
S407Translational Andrology and Urology, Vol 8, Suppl 4 September 2019
  Transl Androl Urol 2019;8(Suppl 4):S398-S417 | http://dx.doi.org/10.21037/tau.2019.08.01© Translational Andrology and Urology. All rights reserved.
that prohibits coupling of high laser powers to small fibers, 
as overfilling of the input fiber core, laser leakage into the 
fiber cladding, and damage to the proximal fiber connectors 
must be prevented (65,132); thus the Ho:YAG laser fibers 
cannot have fiber cores smaller than 200 µm.
However, as described in the Theory section, as the TFL 
laser beam is generated inside a special 10–20 µm laser fiber 
(90,95), substantially higher laser powers can be delivered 
through small-core laser fibers, without damaging the 
fibers (13,95). The highly-focused laser beam exiting the 
tiny fiber core can be directly coupled to another end-stage 
delivery fiber, which can be as small as 50 µm (65,90,114), 
and consequently, the energy density (i.e., the amount of 
energy delivered per stone surface area) can also increase 
considerably (90). In comparison with a 200 µm core fiber, 
a 50 µm core fiber has 16 times less cross-sectional area, 
and will thus deliver a 16 times more-intense laser beam. 
Similar to the advantages resulting from the TFL’s increased 
absorption coefficient, the higher energy density of smaller 
fibers opens a whole new world of possibilities in comparison 
with Ho:YAG lasers: first, the same settings can be used 
to accomplish higher ablation volumes; second, lower 
lithotripter settings can be used to achieve the same results; 
and third, the ability to use very low pulse energies (e.g., 
as low as 0.025 J) and still obtain efficient stone ablation 
results. All these benefits occur simply because of the high 
energy density of the smaller fibers. Although currently only 
fibers as small as 150 µm are being used (12), laboratory 
lithotripsy studies have already been performed using 
50 µm, 100 µm, and 150 µm-core fibers and frequencies over 
1,000 Hz (73,114,133). Even small diameter ball-tip fibers 
with a 100 µm-core have been successfully tested with the 
TFL, and these allowed swift lithotripsy procedures using 
very high frequencies (300 Hz) (134).
The degradation of laser fibers is also significantly 
lower with the TFL than with holmium lasers, with less 
degradation at the proximal (connector) end, as well as less 
fiber burn-back, which improves the fibers lifetime and 
lowers costs (13,65,95). Contrary to the Ho:YAG laser, TFL 
lithotripsy allows 9 mm bending diameters and 50 W high-
power settings to be safely used with regular (200 µm) small-
core fibers (77), while 50 µm-core laser fibers can sustain 
extreme bending with a radius as small as 5 mm, while still 
delivering laser powers of 15 W without breaking (114).
Despite the lower degradation with the TFL, further 
mechanisms and tools are being explored to minimize fiber 
degradation and enhance efficiency even further. These 
include the use of laser fibers with hollow steel tips to reduce 
distal fiber burn-back (135); disposable laser fiber tips to 
provide a cost-effective method to customize and exchange 
fiber tips according to each procedure’s requirements (136); 
laser fibers with short tapered distal fiber tips to expand 
the laser beam and reduce fiber-tip damage and burn-
back without compromising scope deflection, irrigation, or 
lithotripsy efficiency (13); a muzzle brake for the laser fiber 
tip (similar to the ones used in rifles and artillery cannons to 
reduce recoil and redirect propellant gases sideways), which 
reduces stone retropulsion by 85% and provides minimal 
fiber degradation for an efficient stone ablation (19,137); 
and vibrating laser fiber tips to further enhance dusting 
efficiency (138).
With the use of laser fibers with core diameters smaller 
than 200 µm, many other advantages are readily foreseeable 
for (flexible) endoscopy, including better irrigation, 
increased instrument deflection, less retropulsion, and 
even smaller stone fragments. These will all directly and 
indirectly affect accessibility, visibility, efficiency, surgical 
time, and the lithotripsy procedure as a whole (Figure 4) 
(19,41,112,115-117).
Utilization of smaller laser fibers also enables new 
miniaturization opportunities. Laser fibers with integrated 
stone baskets are being developed for the TFL to minimize 
retropulsion, increase flexibility, and reduce laser-induced 
nitinol wire damage (139). Inside the single working 
channel of a ureteroscope, a 50 µm core-diameter fiber 
also consumes approximately 30 times less cross-sectional 
area than the standard 270 µm-core fiber currently used 
in the clinic (114). The standard 1.2 mm (3.6 French/
Charriere) flexible ureteroscope working channel is 
probably excessively large for such small diameter fibers, 
and could undergo further miniaturization (132). With that 
consideration, miniature distal tip scope designs for the 
TFL are being developed, allowing ureteroscope diameters 
of only 4.5 Fr (1.5 mm in diameter) (132), and these should 
have a positive impact on morbidity and make an already 
minimally invasive technique even less invasive (140,141). 
Tissue applications of the TFL
Despite being outside of the scope of this systematic review, 
the authors consider it important to mention that the TFL’s 
higher water absorption directly translates into lower tissue 
ablation thresholds (65,88); thus it is expected to be better 
than the Ho:YAG laser for soft-tissue applications, as briefly 
summarized below. 
One such recently developed soft-tissue application is 
TFL enucleation of the Prostate (ThuFLEP), which is 
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similar to HoLEP. Recent studies have shown ThuFLEP to 
be a safe and highly efficacious treatment modality for the 
management of large volume (> 80 cm3) glands in benign 
prostatic hyperplasia (BPH) (142,143). Even for giant 
BPH gland management (>200 cm3), ThuFLEP has been 
demonstrated as a faster and safer treatment option, with 
faster recovery than retropubic simple prostatectomy (144). 
ThuFLEP was shown to be as efficacious as transurethral 
resection of the prostate (TURP), with shorter operative, 
catheterization, and hospitalization times (145), as well as 
better preservation of erectile function (146). ThuFLEP has 
also been demonstrated to be superior to robotic assisted 
simple prostatectomy, with shorter OR time, less blood 
loss, and fewer complications (147). In comparison with 
HoLEP and monopolar enucleation of the prostate (MEP), 
ThuFLEP was slightly superior, with 25% and 42% faster 
enucleation rates, respectively, although the differences did 
not reach statistical significance (the study was probably 
underpowered) (142). ThuFLEP also seems to be quicker 
for the operator to learn than other enucleation techniques 
such as MEP (142,148). 
Other soft-tissue applications have also been described, 
such as TFL en-bloc enucleation of bladder tumors (149). 
One expert foresaw the potential applications of the TFL 
and its better suitability for more precise incision of soft 
tissues, more rapid prostate ablation, and more efficient 
laser lithotripsy (150). It is logical to presume that any other 
technique being conducted with the Ho:YAG laser can also 
be performed at least as efficaciously and safely with the 
TFL, including ablation and resection of other tissues and 
tumors such as upper tract urothelial carcinomas (UTUC) 
and stricture disease management (11,151,152).
Form factor and environmental impact
Size and weight
Despite the TFL’s much better performance, the machines 
are smaller than Ho:YAG laser lithotripters. One of the 
current 55 W TFL prototypes measures only 55 cm × 
46 cm × 29 cm, and weighs only 36 kg with all its 
components; it uses a simple fan as the cooling mechanism, 
which helps make it quite compact (12). In comparison with 
high-power Ho:YAG lasers that measure at least half a cubic 
meter, weigh 245–300 kg, and use liquid-based chillers to 
provide cooling water (46,50,68), the TFL is seven times 
smaller and eight times lighter (Figure 5). In a time when ORs 
are already cramped with medical equipment, a bulky laser 
lithotripter only worsens the problem. However, the TFL 
can fit inside an endoscopy tower/cart along with the other 
electronic equipment and devices, and the video monitor, 
thereby saving precious OR space. This convenience means it 
can sit next to the surgeon ready for use, should the decision 
to perform a laser procedure be made.
Energy consumption and efficiency
High-power Ho:YAG lasers consume 8,000–10,000 W of 
electrical power (46,50,68). The TFL consumes almost 10 
times less, with a maximum electricity consumption of 800–
1,000 W (12), and is therefore more environmentally friendly. 
To illustrate the point, the electricity consumed by a simple 
household hairdryer would be enough to power at least 
two TFL lithotripter machines at the same time. Although 
lasers are not the most energy efficient machines (153), 
the wall-plug efficiency (the amount of electrical energy 
transformed into laser energy) of the TFL is 12%, which 
is substantially better than that of the Ho:YAG laser, which 
has an efficiency of only 1–2% (65,153). The remaining 98–
99% of the energy is wasted in the form of heat and used in 
heat-reducing processes (Figure 5). Table 1 summarizes most 
of the machine-related specifications. 
Maintenance and other costs
Because diode-pumped lasers such as the TFL have a 
higher wall-plug efficiency, the electronically-modulated 
laser diodes only need small power supplies. As there are 
almost no moving parts, a simple air-cooling mechanism is 
sufficient. The lifetimes of laser diodes are very long (often 
well above 10,000 hours), and there are no lenses or mirrors 
prone to contamination and misalignment (65,94). It is only 
logical to conclude that the wear and tear of the machine 
will be low and the maintenance costs should be minimal. 
On the contrary, flash lamp-pumped rod lasers such as the 
Ho:YAG laser require high-voltage power supplies, the 
lifetime of the flash lamps is limited, they need large and 
complex water cooling systems with multiple moving parts, 
and their optical system is fairly complex. Thus, Ho:YAG 
lasers are much more prone to failure with more wear and 
tear, and have a higher maintenance cost than TFLs, in 
addition to their high acquisition costs (15,65,153).
Another cost-related issue concerns the electrical 
installation of the OR. While the TFL works with a 
standard power outlet (e.g., 5 Amps at 220 V), high-
power Ho:YAG lasers need a dedicated power supply (up 
to 46 Amps), sometimes even requiring a three-phase 
power supply (Figure 5). This may require an overhaul 
of the electrical installation of the OR with its associated 
costs, as well as creating mobility restrictions inside the 
OR (12,46,50,68). Additionally, laser fiber-related costs 
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are likely to be reduced with the TFL because the TFL’s 
uniform beam profile results in lower degradation of fibers 
(95,114). Following this line of thought, the TFL would 
probably be a better candidate for the use of reusable fibers 
than the Ho:YAG laser. 
In a time when healthcare-related costs keep on rising, 
including those for laser lithotripsy, the cost-related issues 
mentioned previously become even more important 
(65,154,155). 
Safety profile
So far, the TFL has been demonstrated to be a safe 
alternative to the Ho:YAG laser for lithotripsy for all 
types of stones in all relevant anatomical regions, as well 
as for ThuFLEP and en-bloc enucleation of bladder 
tumors, with significant reduction in the likelihood of 
intraoperative trauma and postoperative complications 
(79,84,97,106,107,147,156). Many of the above-mentioned 
advantages of the TFL (significantly higher efficiency, 
speed, less retropulsion, smaller fragments, and shorter 
operating time) also contribute to reduce patient morbidity 
and complications, some directly and others indirectly. 
Likewise, the potential to use much smaller laser fibers with 
the TFL and all the ensuing advantages (better accessibility, 
visibility, and efficiency) further reduce the operating time 
and patient risk. The lower fiber degradation rate and 
resistance under extreme working deflections also make it 
safer, in particular for flexible scopes (13,19,41,65,95,112,11
4,116,117,157). 
Patient and instrument safety at laser delivery point
The higher water absorption coefficient makes the TFL 
an even safer instrument than the Ho:YAG laser, the latter 
being considered safe for both the patient and instruments 
when properly used. Non-contact TFL ablation studies 
reported ablation stall out at working distances beyond 1.0 
mm. The short TFL working distance and longer ureter 
perforation times may provide a greater safety margin from 
accidental perforation of tissues or damage to instruments 
(e.g., a nitinol stone basket) during laser irradiation, 
especially in comparison with the 4–5 mm maximum 
working distance previously reported for the Ho:YAG laser 
(127,158). Concerning the endoscopic safety distance for 
scopes, keeping the laser fiber tip visualized in 1/4 of the 
field of view of the endoscopic video screen (corresponding 
to a scope-to-fiber-tip distance of approximately 3 mm) 
appears to be safe for the treatment of both soft and hard 
stones or tissues, as demonstrated for the Ho:YAG laser 
(118,159). As for possible intrarenal pressure concerns, laser 
settings per se have not been demonstrated to cause any 
measurable change in intrarenal pressure (160). 
Temperature increase during lithotripsy
Recently, the risk of local temperature rise in the 
kidney or ureter during laser emission has gained broad 
attention, particularly with the use of high-power lasers 
(99,100,161,162). One study using different irrigation 
fluid temperatures with a TFL did not find any significant 
differences in temperature increase in comparison with a 
Ho:YAG laser when using the same pulse frequency and 
energy settings (163). Thus, the same strategies that apply to 
the Ho:YAG laser also apply to the TFL, i.e., always using 
irrigation or cooled irrigation fluid and intermittent laser 
activation to mitigate thermal effects and avoid unnecessary 
damage to the surrounding tissues (19,99,100,164). 
However, when using intermittent laser activation with 
high-power settings, the temperature increase can still be 
dangerously high when irrigation is low (165). Even with 
commonly used irrigation pressures and laser settings 
slightly above 10 W, some authors have documented 
potentially dangerous intra-ureteral temperatures within 
seconds (166). As increasing temperatures also decrease the 
absorption coefficient of water for thulium radiation (86,87), 
and consequently reduce the TFL’s efficiency, this could be 
another argument for the use of irrigation fluid cooled to at 
least 20 ℃ to ensure maximum efficiency and safety.
Radiation and electrical hazards
One of the main concerns with laser radiation is eye safety (19). 
With its 1,940 nm wavelength, the TFL is far less 
dangerous than other lasers, as lasers emitting wavelengths 
longer than 1,400 nm are often referred to as being “eye-
safe” because the light in this wavelength range is strongly 
absorbed in the eye’s cornea and lens, and cannot therefore 
reach the substantially more sensitive retina (167). This 
has already been studied and verified for the Ho:YAG laser 
(168,169). Considering that the absorption length at the 
TFL wavelength for the cornea is very small (well below 
0.1 mm) (167) and that the TFL has a much shorter optical 
penetration depth (see Theory section), the TFL is expected 
to be even more “retina-safe” than the Ho:YAG laser. 
With regard to electrical safety, all electrical appliances 
and medical equipment must go through regulated quality 
control and so should be safe to use in this respect (170). 
Unlike Ho:YAG lasers, the TFL does not use high-voltage 
power supplies or three-phase high-amperage power outlets 
that could give rise to additional safety issues (153), and the 
TFL is therefore, in theory, a safer machine with respect to 
electrical-related hazards.
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Noise level
One of the most overlooked safety hazards in Medicine 
(171,172) is the noise level. Most experienced readers are 
likely to agree that a working high-power Ho:YAG laser in 
the OR is quite noisy, and can make communication in the 
OR more difficult. Existing studies on the noise levels of 
laser lithotripsy are rare, but it has been shown that high-
power Ho:YAG lasers produce sound levels up to 70 dB, 
which are higher than those of other technologies and 
exceed the widely stated 55 dB limit for work requiring 
concentration, or the normal communication protective 
level (at 60 dB). Such noise levels can also negatively affect 
surgeons by increasing with statistical significance their 
systolic blood pressure (173,174). The simple fact that one 
of the most recent Ho:YAG lasers includes a “silent mode” 
is a further indication of this noise-hazard problem (49). 
Fortunately,  due to i ts  internal  components  and 
construction, the TFL is significantly quieter than Ho:YAG 
flash lamp-pumped lasers (94,153), providing a calmer and 
less noisy working environment.
Limitations
This review has a key limitation common to all studies on 
very new technologies, namely, the low number of studies 
available upon which to base the conclusions. Despite this 
drawback, the authors have tried to remain as objective as 
possible, providing and summarizing the best evidence-
based information available, and allowing the reader to 
make their own judgment. With consideration of the 
adherence of this review to PRISMA guidelines and the 
limited number of studies about the TFL, including in vitro 
laboratory studies and small clinical series, it did not make 
sense to perform an individual study-level or outcome-
level assessment of the risk of bias (20), which could be 
considered another limitation.
Conclusions
The Ho:YAG laser has stood the test of time; it has been 
extensively studied and has become the gold-standard for 
laser lithotripsy since its first appearance over 30 years 
ago. Nevertheless, the apparent advantages of the TFL 
over the Ho:YAG laser (several times higher efficiency, 
wider and more comprehensive parameter combinations, 
significantly reduced retropulsion, ease of use, versatility, 
scope miniaturization possibilities, system compactness, 
foreseeable component durability, and increased safety 
profile) are simply too extensive to be ignored. The TFL 
appears to be a real alternative to the Ho:YAG laser, with 
the potential to become a true game-changer in laser 
lithotripsy. Due to its novelty, further studies are needed to 
broaden our understanding of the TFL, and comprehend 
the full implications and benefits of this new technology, as 
well its limitations.
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